Direct global supply of biological raw materials manufactured under strict GMP compliance standards.
Analyzing the therapeutic synergy of Palmitoylethanolamide and Luteolin in chronic neuroinflammation mitigation and microglial regulation.
In the rapidly advancing functional health sector, Mirica capsules have emerged as a benchmark formulation for combating chronic discomfort and neuroinflammatory conditions. The combination of Palmitoylethanolamide (PEA) and Luteolin acts synergistically to regulate immune responses and stabilize mast cells, offering relief to individuals with chronic pain, brain fog, and autoimmune sensitivities. As the global demand for safe, non-addictive pain management alternatives accelerates, international buyers are increasingly searching for a reliable, large-scale China Mirica capsules exporter who can navigate complex production protocols and secure raw ingredient consistency.
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide that belongs to the N-acylethanolamine family. It targets the peroxisome proliferator-activated receptor-alpha (PPAR-α), which plays a key role in pain signaling pathways and inflammatory cascades. Concurrently, Luteolin, a naturally occurring flavonoid extracted from botanical sources like Sophora japonica, acts as a potent antioxidant and microglial activation inhibitor.
When combined, PEA and Luteolin achieve a dual-action mechanism: PEA works to downregulate peripheral mast cell activation and nociception pathways, while Luteolin crosses the blood-brain barrier to reduce neuroinflammatory cytokines. This dynamic makes the Mirica formula highly sought after in modern clinical nutrition. Chengdu Chenlv Herb, with years of expertise in botanical processing and extraction, provides consistent, high-purity raw materials and contract manufacturing services for this formulation.
By controlling the entire process from botanical cultivation to final capsule manufacturing, we guarantee the safety and reliability that global distributors require.
Leveraging advanced manufacturing technologies, strategic regional sourcing, and strict quality control processes to ensure supply chain stability.
Our facility controls the extraction of luteolin and the synthesis/purification of PEA in-house. This internal integration reduces processing costs, ensures traceability, and prevents contamination from outside suppliers.
To address the absorption limitations of lipophilic compounds like PEA, we utilize micronization technology. Reducing particle size increases the surface area, improving dissolved levels and enhancing overall bioavailability.
Operating out of our modern 9,514㎡ manufacturing complex, we manage automated encapsulation and packaging lines. This large-scale infrastructure allows us to fulfill bulk orders quickly and maintain supply consistency.
Chengdu ChenLv Herb Co.,Ltd. was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, active, and premium-quality raw materials, we serve diverse global industries, including pharmaceuticals, health supplements, food, and cosmetics.
Integrating research and development, manufacturing, and international distribution.
Meeting complex regulatory requirements and technical documentation standards across major international markets.
Products in the health and supplement sectors receive significant scrutiny from search engines and regulatory bodies alike. As a trusted raw material partner, we provide complete, transparent documentation to assist with compliance requirements.
We supply comprehensive validation files with every batch, including certificate of analysis (COA) data, allergen declarations, BSE/TSE statements, and heavy metal testing reports. Our production processes are designed to meet FDA, EFSA, and local market regulatory expectations.
How Chenlv Herb facilitates collaborative contract manufacturing from concept to container shipping.
Aligning project goals, product specifications, and desired ingredient concentrations.
Providing transparent cost models based on volume commitments and raw material parameters.
Establishing supply agreements, delivery timelines, and target testing metrics.
Developing and adjusting prototype runs to verify taste stability, texture, and density.
Scaling capsule filling, tablet runs, and primary packaging within GMP-controlled environments.
Performing final microbiology and chemical screenings to issue batch release certificates.
Coordinating international sea, air, and express shipments with customs clearance documentation support.
How our ingredients are adapted across diverse wellness sectors.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have become core raw materials for health care product development due to their natural profiles.
From traditional herbal formulas to modern therapeutic agents, botanical extracts maintain an important position in the pharmaceutical industry due to their targeted active ingredients.
As consumer demand shifts toward clean and sustainable skincare, plant extracts are widely utilized in cosmetics for their gentle profiles, skin compatibility, and functional properties.
Botanical extracts show potential in supporting animal digestive health, natural immunity, and overall vitality, making them a growing segment in agricultural feed formulations.
Our manufacturing sites and processes hold major international standards certifications, including ISO9001, ISO22000, HALAL, KOSHER, and FDA registrations.
Updates on raw material market dynamics and upcoming global pharmaceutical exhibitions.
Recently, the market price of Citrus aurantium raw materials in China has shown upward movement, drawing attention across the industry. As the new harvest season draws to a close, price stability has become a key focus due to shifting supply-demand dynamics and overall production costs.
As a platform connecting China's pharmaceutical industry with the global market, the 23rd China Pharmaceutical Ingredients Exhibition (CPHI China 2025) will co-locate with the 18th China Pharmaceutical Machinery Exhibition to highlight new technical innovations.
The 92nd China International Pharmaceutical Ingredients / Intermediates / Packaging / Equipment Fair (API China) will host industry partners in Guangzhou to share technical developments in biotechnology and formulation design.
Professional answers regarding Mirica formulation, PEA micro-crystallization, contract manufacturing options, and export logistics.
Explore our certified standardized extracts and natural active ingredients for global formulations.
Chenlv Herb
